A narrative review of the naturally occurring inhibitory neurotransmitter gamma-aminobutyric acid (GABA) called phenibut in dietary supplements

1998 Barnard, 2017, The highs and lows of NPS/Legal High use: Qualitative views from a UK online survey, Drugs: Education, Prevention and Policy, 24, 96 Brunner, 2017, Case report of physiologic phenibut dependence treated with a phenobarbital taper in a patient being treated with buprenorphine, Journal of Addiction Medicine, 11, 239, 10.1097/ADM.0000000000000303 Dolengevich-Segal, 2017, An approach to the new psychoactive drugs phenomenon, Salud Mental, 40, 71, 10.17711/SM.0185-3325.2017.010 Downes, 2015, Acute behavioural disturbance associated with phenibut purchased via an internet supplier, Clinical Toxicology, 53, 636, 10.3109/15563650.2015.1059945 EMCDDA, 2014 EMCDDA-Europol, 2005 Goldblat, 1986, Potentiation of the therapeutic effect of antiparkinsonian drugs by phenibut, Zhurnal Nevropatologii i Psikhiatrii, 86, 1146 Högberg, 2013, Psychotic symptoms during phenibut (beta-phenyl-gamma-aminobutyric acid) withdrawal, Journal of Substance Use, 18, 335, 10.3109/14659891.2012.668261 Henselmans, 2015 Khaunina, 1989, Use of phenibut in psychoneurology and its place among other psychotropic drugs, Zhurnal nevropatologii i psikhiatrii, 89, 142 Khaunina, 1968, Structure-activity relationships among phenyl derivatives of ã-aminobutyric acid, Farmakologiia I Toksikologiia, 2, 202 Khaunina, 1971, The pharmacological activity of optic isomers of beta-phenyl-gamma-ammobutync acid, Biulleten' eksperimental'noĭ biologii i meditsiny, 11, 49 Khaunma, 1964, Tranquillizing effects of â-phenyl-ã-aminobutyric acid (Phenigama), Biulleten' eksperimental'noĭ biologii i meditsiny, 1, 54 Lapin, 1964, Pharmacology and clinical use of gamma-aminobutyric acid and its derivatives, 101 Lapin, 2001, Phenibut (beta-phenyl-GABA) a tranquilizer and nootropic drug, CNS Drug Review, 7, 471, 10.1111/j.1527-3458.2001.tb00211.x Li, 2015, An uncommon case of phenibut toxicity in an intensive care bunit, International Journal of Medical and Pharmaceutical Case Reports, 5, 1, 10.9734/IJMPCR/2015/21689 Magsalin, 2010, Withdrawal symptoms after internet purchase of phenibut (β-phenyl-γ-aminobutyric acid HCL), Journal of Clinical Psychopharmacology, 30, 648, 10.1097/JCP.0b013e3181f057c8 Maslova, 1965, Distribution of â-phenyl-ã-aminobutyric acid in the body and certain indices of its central effects, Biulleten' eksperimental'noĭ biologii i meditsiny, 8, 65 Maslova, 1967, Penetration of gamma-aminobutyric acid and its phenyl derivative into the brain and their pharmacological effects in mice and rats during ontogenesis, Evol Neirofiziol Neirokhim, 5, 186 Merchan, 2016, Phenibut overdose in combination with fasoracetam: Emerging drugs of abuse, Journal of Clinical Intensive Care and Medicine, 1, 001, 10.29328/journal.jcicm.1001001 O'Connell, 2014, Phenibut, the appearance of another potentially dangerous substance in the United States, American Journal of Medicine, 127, e3, 10.1016/j.amjmed.2014.03.029 Odujebe, 2008, Phenibut withdrawal –a novel nutritional supplement Owen, 2016, Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity, Drug and Alcohol Review, 35, 591, 10.1111/dar.12356 ReDNet Research Group, 2012 Ronn, 2003, Serotonin syndrome or phenibut overdose: A case study, Journal of the American Pharmaceutical Association, 53 Samokhvalov, 2013, Phenibut dependence, BMJ Case Reports., 2013 Sankary, 2017, Phenibut overdose, American Journal of Emergency Medicine, 35, 10.1016/j.ajem.2016.08.067 Schifano, 2017, Is there a potential of misuse for Magnolia officinaliscompounds/metabolites?, Human Psychopharmacology: Clinical and Experimental, 32, e2577, 10.1002/hup.2595 Schifano, 2015, Novel psychoactive substances (NPS): Clinical and pharmacological issues, Drugs and Alcohol Today, 15, 21, 10.1108/DAT-10-2014-0035 Schmitt, 2013, Use of phenibut in France: Report of two cases, Therapie, 68, 123, 10.2515/therapie/2013014 Sutherland, 2017, New psychoactive substances: Purchasing and supply patterns in Australia, Human Psychopharmacology: Clinical and Experimental, 32, 2577, 10.1002/hup.2577 UNODC, 2013, 10.18356/d30739c2-en Van Hout, 2017, New Psychoactive Substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors, International Journal of Drug Policy, 40, 102, 10.1016/j.drugpo.2016.11.007 Van Hout, 2014, Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions, Drug Testing & Analysis, 6, 778, 10.1002/dta.1622 Wong, 2015, Analytically confirmed recreational use of phenibut (β-phenyl-γ-aminobutyric acid), Clinical Toxicology, 53, 783, 10.3109/15563650.2015.1059944